Nath Bio-Genes (India) Ltd

Nath Bio-Genes | 537291

Market Closed

₹164.76

+₹1.95 (+1.20%)

As on 11/07/26, 5:14 AM

Market Cap313.11 CR

Current Price₹164.76

High / Low₹238.69 / 126.15

PE Ratio7.18

Book Value₹339.08

Dividend Yield1.37%

ROCE6.86%

ROE6.69%

Face Value₹2.00

Current Vol.4,136

Average Vol.---

ISININE448G01010

PB Ratio0.43

Debt to Equity0.19

Net Profit Margin10.58

Operating Margin15.09

Share Price Chart - Nath Bio-Genes (India) Ltd

+₹0.00 (+0.00%)6M

Stock Performance

₹162.8₹164.98

₹164.76

Previous CloseToday's Open

₹126.15₹238.69

₹164.76

52W Low52W High

₹164.98Today's Open

₹162.8Previous Close

4,136Volume

₹126.1552W Low

₹238.6952W High

Ratios

No data available

About Company

Nath Bio-Genes (India) Limited was originally incorporated in the name and style of 'Shivnath Farms Private Limited' as Private Limited Company which thereafter was converted into Public Limited Company on 13 September, 2000 under the name and style of Shivnath Farms Limited' and further changed from Shivnath Farms Limited to Nath Bio-Genes (India) Limited on March 05, 2001
The Company stands as a distinguished leader in the Indian seed industry, leveraging over two decades of expertise in producing and distributing high-quality seeds to Indian farmers
The Company's robust research and development initiatives have yielded numerous acclaimed cotton seed varieties, noted for their resilience against viruses and weather fluctuations, as evidenced by their outstanding performance in ICAR trials
The Company's commitment to excellence is further demonstrated through its comprehensive extension programs designed to empower farmers
These initiatives include product awareness campaigns, crop demonstrations, agronomic input guidance, fertigation practices, and post-harvest management training
As Nath Bio-Genes transitions from addressing food security to focusing on nutritional security, the Company is dedicated to bringing healthier seed varieties from farms to consumers' plates
This strategic shift underscores the ongoing mission to support farmers and contribute to overall well being of the population through innovative agricultural solutions
Presently, the Company is engaged in the business of production, processing, and marketing of hybrid and GM seeds
The Company has a product into field crops, vegetable crops and plant nutrient supplements
The major processing plants are situated at Aurangabad (MS), and Munipalli, Nizamabad (TG)

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI46.87

SMA 20166.63

SMA 50169.59

SMA 100159.53

SMA 200159.32

SMA 10165.76

MACD_12_26_Days-1.02

EMA10Day165.67

EMA20Day166.66

EMA50Day166.12

MACD_12_26_9_Days-0.37

EMA100Day163.39

EMA200Day164.36

Pivot Points

Volume Analysis

Delivery

Total Volume

Growth Rate

Revenue Growth9.71%

ROE6.15%

EBITDA Margin15.09%

All figures in ₹ Crores

Indicators	2025	2024	2023	2022	2013
Revenue	364.91	332.62	301.36	278.36	137.70
Interest	10.48	9.11	10.12	10.61	3.67
Expenses	315.11	282.76	252.62	241.17	117.80
Financing Profit	54.34	50.49	49.30	39.04	20.48
Financing Margin %	15%	15%	16%	14%	15%
Other Income	4.55	0.63	0.55	1.85	0.58
Depreciation	3.82	3.26	3.01	3.08	4.51
Profit before tax	40.58	41.56	36.16	-63.43	12.30
Tax %	5%	5%	3%	-6%	4%
Net Profit	38.60	39.62	35.01	-67.39	11.75
EPS in Rs	20.14	21.34	18.43	-35.55	7.34

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

📊

No Data Available

No Block Deals data available for this company.

News

📊

No Information Available

No news available for this company.

Record Date

Corporate Action

Information

Announcement Day

22 Aug 2025

AGM

29 Apr 2025

14 Aug 2025

Final Dividend (₹2)

The Board on meeting held today on 29th April 2025 has approved the following. In continuance to our intimation dated April 21st 2025, after due deliberation the Board of Directors has recommended dividend for financial year 2024-25 of Rs. 2/-(i.e. 20%) per equity shares of the nominal value of Rs. 10.00 per share fully paid up, subject to approval of shareholders in upcoming Annual General Meeting of the Company Notice of 32nd Annual General Meeting. (As Per BSE Announcement Dated on: 31/07/2025)

29 Apr 2025

17 Aug 2024

AGM

08 May 2024

09 Aug 2024

Final Dividend (₹2)

In continuance to our intimation dated April 30th 2024, after due deliberation the Board of Directors has recommended dividend for financial year 2023-24 of Rs. 2/-(i.e. 20%) per equity shares of the nominal value of Rs. 10.00 per share fully paid up, subject to approval of shareholders in upcoming Annual General Meeting of the Company. Record date for AGM and Dividend is Friday 09th August 2024 (As Per BSE Announcement dated on 23.07.2024)

08 May 2024

12 Mar 2024

EGM

18 Jan 2024

11 Jul 2023

AGM

22 Apr 2023

30 Jun 2023

Final Dividend (₹2)

The outcome of the Board Meeting held on 22nd April 2023. In continuance to our intimations dated April 15th 2023, after due deliberation the Board of Directors has recommended dividend for financial year 2022-23 of Rs. 2/-(i.e. 20%) per equity shares of the nominal value of Rs. 10.00 per share fully paid up, subject to approval of shareholders in upcoming Annual General Meeting of the Company Book Closure and record date for upcoming AGM The registrar of members and share transfer book of the Company will be closed from 25th June 2023 to 30th June 2023 for the purpose of holding Annual General Meeting and Declaration of Dividend. Kindly note that the record date is 23rd June 2023 for the purpose of AGM and Dividend. (As per BSE Announcement Dated on 25/04/2023) Intimation for Change in Book Closure and Record Date (As Per BSE Announcement dated on 23.05.2023)

22 Apr 2023

30 Jun 2022

AGM

30 May 2022

25 Jun 2022

Final Dividend (₹2)

Nath Bio-Genes (India) Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2022, inter alia, has recommended dividend for financial year 2021-22 of Rs. 2/- (i.e. 20%) per equity shares of the nominal value of Rs. 10.00 per share fully paid up, subject to approval of shareholders in upcoming Annual General Meeting of the Company.

30 May 2022

27 Aug 2021

AGM

24 Jun 2021

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Net Profit Ratio(%)
164	311	9	0	8	10.58%
2,149	5,04,998	33	10	31	23.65%
1,457	2,80,888	83	54	68	14.52%
478	1,61,733	51	8	36	13.78%
5,354	1,28,954	51	25	45	12.14%
1,089	1,11,402	55	9	49	11.75%
853	1,10,687	63	26	56	13.22%
543	94,465	188	11	61	3.73%
443	78,666	42	7	33	14.16%
414	45,037	22	3	20	3.81%

Showing 10 of 105 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

DIXONDixon Technologies (India) Ltd
₹13,421-56 (-0.42%)

Frequently Asked Questions

What is Share Price of Nath Bio-Genes (India) Ltd?

The current share price of Nath Bio-Genes (India) Ltd (Nath Bio-Genes) is ₹164.76. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Nath Bio-Genes (India) Ltd?

The Price-to-Earnings (P/E) ratio of Nath Bio-Genes (India) Ltd is 164.76. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Nath Bio-Genes (India) Ltd?

Nath Bio-Genes (India) Ltd has a 52-week high of ₹238.69 and a 52-week low of ₹126.15. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Nath Bio-Genes (India) Ltd?

Nath Bio-Genes (India) Ltd offers a dividend yield of 1.23%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Nath Bio-Genes (India) Ltd?

The Earnings Per Share (EPS) of Nath Bio-Genes (India) Ltd is ₹19.06. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Nath Bio-Genes (India) Ltd?

Nath Bio-Genes (India) Ltd has a Return on Equity (ROE) of 6.69%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds. Play Video